Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Desogestrel Prior to Etonogestrel Subdermal Implant
NCT05174195Terminated
- Start
- Aug 2016
- Primary completion
- Mar 2018
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of desogestrel in contraception (2 arms). Primary endpoint: Tolerance of Implanon at 1 year. Started Aug 2016; status: terminated.
02
Drugs
desogestrel
03
Conditions
contraception
Beyond the preview
Go deeper on NCT05174195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05174195.